Fort, L.P. Bristol Myers Squibb CO Transaction History

Fort, L.P.

$38.5 Million
Q2 2024

A detailed history of Fort, L.P. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Fort, L.P. holds 5,000 shares of BMY stock, worth $265,950. This represents 0.54% of its overall portfolio holdings.

Number of Shares

5,000

Previous 4,208 18.82%

Holding current value

$265,950

Previous $228,000 9.21%

% of portfolio

0.54%

Previous 0.58%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$40.25 - $52.99 $31,878 - $41,968	792 Added 18.82%	5,000 $207,000
Q1 2024 May 14, 2024	BUY	$47.98 - $54.4 $1,103 - $1,251	23 Added 0.55%	4,208 $228,000
Q3 2023 Nov 13, 2023	BUY	$57.89 - $64.73 $10,072 - $11,263	174 Added 4.34%	4,185 $242,000
Q2 2023 Aug 11, 2023	SELL	$63.71 - $70.74 $6,243 - $6,932	-98 Reduced 2.39%	4,011 $256,000
Q1 2023 May 12, 2023	SELL	$65.71 - $74.53 $108,881 - $123,496	-1,657 Reduced 28.74%	4,109 $284,000
Q4 2022 Feb 13, 2023	SELL	$68.48 - $81.09 $147,916 - $175,154	-2,160 Reduced 27.25%	5,766 $414,000
Q3 2022 Nov 10, 2022	SELL	$0.13 - $76.84 $712 - $421,160	-5,481 Reduced 40.88%	7,926 $563,000
Q2 2022 Aug 12, 2022	SELL	$72.62 - $79.98 $655,613 - $722,059	-9,028 Reduced 40.24%	13,407 $1.03 Million
Q1 2022 May 13, 2022	SELL	$61.48 - $73.72 $90,314 - $108,294	-1,469 Reduced 6.15%	22,435 $1.64 Million
Q4 2021 Feb 11, 2022	BUY	$53.63 - $62.52 $19,467 - $22,694	363 Added 1.54%	23,904 $1.49 Million
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $129,523 - $151,719	-2,189 Reduced 8.51%	23,541 $1.39 Million
Q2 2021 Aug 13, 2021	SELL	$61.91 - $67.42 $88,655 - $96,545	-1,432 Reduced 5.27%	25,730 $1.72 Million
Q1 2021 May 14, 2021	BUY	$59.34 - $66.74 $78,150 - $87,896	1,317 Added 5.1%	27,162 $1.72 Million
Q4 2020 Feb 12, 2021	BUY	$57.74 - $65.43 $334,025 - $378,512	5,785 Added 28.84%	25,845 $1.6 Million
Q3 2020 Nov 13, 2020	BUY	$57.43 - $63.64 $99,698 - $110,479	1,736 Added 9.47%	20,060 $1.21 Million
Q2 2020 Aug 13, 2020	SELL	$54.82 - $64.09 $1.61 Million - $1.88 Million	-29,344 Reduced 61.56%	18,324 $1.08 Million
Q1 2020 May 14, 2020	SELL	$46.4 - $67.43 $229,076 - $332,901	-4,937 Reduced 9.39%	47,668 $2.66 Million
Q4 2019 Feb 13, 2020	BUY	$49.21 - $64.19 $1.51 Million - $1.97 Million	30,740 Added 140.59%	52,605 $3.38 Million
Q3 2019 Nov 13, 2019	BUY	$42.77 - $50.71 $648,222 - $768,560	15,156 Added 225.91%	21,865 $1.11 Million
Q2 2019 Aug 13, 2019	BUY	$44.62 - $49.34 $254,914 - $281,879	5,713 Added 573.59%	6,709 $304,000
Q1 2019 May 14, 2019	BUY	$45.12 - $53.8 $18,454 - $22,004	409 Added 69.68%	996 $48,000
Q4 2018 Feb 13, 2019	BUY	$48.76 - $63.23 $2,486 - $3,224	51 Added 9.51%	587 $31,000
Q3 2018 Nov 13, 2018	BUY	$55.19 - $62.25 $29,581 - $33,366	536 New	536 $33,000

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fort, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Fort, L.P. with notifications on news.

Account